1. HOME
2. Research Insight
3. Vaccines Manufacturers - Pfizer Inc. (US), Pfizer Inc. (US) and Moderna, Inc. (US) are the Key Manufacturers

The vaccines market (including COVID-19 vaccines) is projected to reach USD 94.9 Billion by 2029 from USD 78.0 Billion in 2024, at a CAGR of 4.0% during the forecast period. Similarly the vaccines market (excluding COVID-19 vaccines) is projected to reach USD 80.3 Billion by 2029 from USD 53.0 Billion in 2024, at a CAGR of 8.7% during the forecast period. Technological advancements in vaccine development, increasing government initiatives for immunization programs and expanding investments in research and development are some of the factors driving growth of vaccines market.

The vaccines market is highly competitive.

Major Vaccines Market manufacturers include:

• Pfizer Inc. (US),
• Johnson & Johnson (US),
• Moderna, Inc. (US),
• AstraZeneca plc (UK),
• Sanofi Pasteur (France),
• GlaxoSmithKline plc (GSK) (UK),
• Merck & Co., Inc. (US),
• Novavax, Inc. (US),
• Serum Institute of India (India), and among others.

These manufacturers play pivotal roles in advancing vaccine research, development, and production, contributing to the growth and evolution of the global vaccines industry. Their diverse expertise, technologies, and collaborative efforts are essential for addressing current and future public health challenges.

To know about the assumptions considered for the study download the pdf brochure

Pfizer Inc. (US)

Pfizer is one of the largest pharmaceutical companies globally and has a significant presence in the vaccines market. It has developed several vaccines, including those for COVID-19, such as the Pfizer-BioNTech COVID-19 vaccine.

Role in Industry Growth: Pfizer's advancements in vaccine technology, particularly its mRNA vaccine platform used in the COVID-19 vaccine, have revolutionized vaccine development. Its collaborations with other companies, such as BioNTech, have accelerated vaccine research and production.

Johnson & Johnson (US)

Johnson & Johnson is a multinational corporation with diversified healthcare products, including vaccines. Its COVID-19 vaccine, developed by its subsidiary Janssen Pharmaceuticals, is a viral vector vaccine.

Role in Industry Growth: Johnson & Johnson's COVID-19 vaccine, which requires only one dose, has contributed significantly to global vaccination efforts, particularly in regions with logistical challenges. Its viral vector technology has added diversity to vaccine platforms available in the market.

Moderna, Inc. (US)

Moderna is a biotechnology company known for its mRNA vaccine technology. Its COVID-19 vaccine, mRNA-1273, was one of the first authorized for emergency use.

Role in Industry Growth: Moderna's success with mRNA vaccines has opened new avenues for vaccine development against various diseases. Its platform offers advantages in rapid development and scalability, potentially shortening the timeline for vaccine production in future outbreaks.

AstraZeneca plc (UK)

AstraZeneca is a global pharmaceutical company that developed the COVID-19 vaccine in collaboration with the University of Oxford. The vaccine, AZD1222, uses a viral vector platform.

Role in Industry Growth: AstraZeneca's vaccine has been crucial for global vaccine equity due to its affordability and ease of distribution, particularly in low- and middle-income countries. Its partnership model has facilitated technology transfer and production scale-up in various regions.

Sanofi Pasteur (France)

Sanofi Pasteur is the vaccines division of Sanofi, a multinational pharmaceutical company. It produces a wide range of vaccines, including those for influenza, polio, and meningitis.

Role in Industry Growth: Sanofi Pasteur's expertise in vaccine development and production, coupled with its global reach, has contributed to expanding access to essential vaccines worldwide. Its ongoing research into new vaccine candidates targets emerging infectious diseases and unmet medical needs.

GlaxoSmithKline plc (GSK) (UK)

GSK is a leading healthcare company with a significant presence in the vaccines market. It produces vaccines for diseases such as influenza, hepatitis, and human papillomavirus (HPV).

Role in Industry Growth: GSK's commitment to innovation and collaboration has led to the development of vaccines that address public health challenges globally. Its partnerships with research institutions and governments support the discovery and development of novel vaccine candidates.

Merck & Co., Inc. (US)

Merck is a multinational pharmaceutical company with a long history of vaccine development. It produces vaccines for diseases such as measles, mumps, rubella, and human papillomavirus (HPV).

Role in Industry Growth: Merck's dedication to research and development has resulted in the introduction of vaccines that prevent significant infectious diseases. Its focus on improving vaccine efficacy, safety, and accessibility contributes to global immunization efforts.

Novavax, Inc. (US)

Novavax is a biotechnology company focused on the development of vaccines using recombinant nanoparticle technology. Its COVID-19 vaccine, NVX-CoV2373, is protein-based.

Role in Industry Growth: Novavax's innovative vaccine platform offers potential advantages in vaccine stability, scalability, and manufacturability. Its COVID-19 vaccine candidate provides another option for global vaccination campaigns, particularly in regions where other vaccines may be less accessible.

Related Reports:

Vaccines Market by Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, RSV), Route of Administration - Global Forecast to 2029